GI Societies Fight CMS on Colonoscopy Pay Cuts

AGA, along with our sister societies, is committed to fighting CMS-proposed cuts to colonoscopy for 2016.

FDA Approves New Device to Treat Obesity

AGA Perspectives: Wave of the Future

Is chromoendoscopy becoming the standard technique for colon cancer surveillance in IBD patients? Read the latest issue of AGA Perspectives to find out.

Opportunity to Get Involved with AGA

Money scope

GI Societies Fight CMS on Colonoscopy Pay Cuts

man measuring waist

FDA Approves New Device to Treat Obesity

Wave

AGA Perspectives: Wave of the Future

Teamwork

Opportunity to Get Involved with AGA

News

Filter
  • All
  • Celiac Disease
  • Colorectal Cancer
  • Endoscopy
  • GERD
  • Hepatitis C
  • IBD
  • Advocacy
  • Cancer prevention and treatment
  • GI practice & quality
  • Gut Microbiome & FMT
  • Hepatology
  • Lower GI disorders & procedures
  • Obesity & nutrition
  • Pancreaticobiliary disorders & procedures
  • Pediatric Gastroenterology
  • Procedures
  • Regulatory Peptides, Cell Signaling & Molecular Biology
  • Upper GI disorders & procedures

News

GI Societies Fight CMS on Colonoscopy Pay Cuts

July 30, 2015

AGA, along with our sister societies, is committed to fighting CMS-proposed cuts to colonoscopy for 2016.

News

Get Your Barrett's Esophagus Slides Today

July 30, 2015

GastroSlides offers a comprehensive, growing collection of over 3,000 images on major GI and liver disease topics.

News

AGA Survey Reveals Respondents’ Views on Biosimilar Drugs

July 30, 2015

91% of AGA members sampled prescribe biologic drugs for their IBD patients.

News

AGA Guidelines Patients Can Understand

July 29, 2015

AGA has developed four patient summaries to help GIs communicate new guidelines effectively and efficiently with their patients.

News

FDA Approves New Device to Treat Obesity

July 29, 2015

ReShape Dual Balloon is the 4th obesity device to be approved by the FDA.

News

AGA Adds Two Free CME Courses to HCV Toolkit Series

July 29, 2015

On-demand resources focus on direct-acting antiviral therapies for HCV; each offers 1.0 AMA PRA Category 1 Credit™.

Press Release

National Survey Reveals Gastroenterologists' Views on Biosimilar Drugs

July 29, 2015

Advertisement

On Demand

Strategies to Monitor Treatment Efficacy and Adherence in HCV

July 29, 2015

This educational monograph presents evidence, national guidelines, and expert views to support a set of 5 strategies for monitoring direct-acting antiviral effectiveness and supporting patients in adhering to their antiviral therapy.